Xybion Digital Inc. announced that it has been awarded a 5-year multi-million US dollar contract by a leading global pharmaceutical company with branches in over 100 countries. Xybion is deploying the Pristima XD module to standardize and simplify lab operations for the client. This win reinforces Xybion's leadership position in the Life Sciences sector and validates the company's strategy of expanding its operations into new geographies globally.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.55 CAD | +22.22% | +12.24% | +11.11% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.11% | 2.12Cr | |
+15.87% | 34TCr | |
+26.33% | 22TCr | |
+7.29% | 16TCr | |
+12.11% | 5.73TCr | |
+20.65% | 3.47TCr | |
+5.22% | 3.11TCr | |
+127.98% | 2.55TCr | |
+30.09% | 2.25TCr | |
+50.88% | 1.53TCr |
- Stock Market
- Equities
- XYBN Stock
- News Xybion Digital Inc.
- Xybion Digital Inc. Receives 5-Year Multi-Million US Dollar Contract with Leading Global Pharmaceutical Company Headquartered in Europe